David Sobel
Papers
3
Total Citations
25
H-Index
3
About
David Sobel is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes and patient safety, particularly in the context of robotic-assisted procedures and emerging clinical challenges. His key research areas include venous thromboembolism (VTE) prophylaxis, infection control, and the integration of novel technologies in urologic oncology. Sobel’s major contributions include demonstrating the feasibility of direct oral anticoagulants for VTE prevention after robot-assisted radical cystectomy, a study with 14 citations that offers a practical alternative to traditional heparin-based regimens. He also led a critical investigation into personal protective equipment (PPE) use during the COVID-19 pandemic, cataloging practice changes across common urologic procedures and earning 7 citations for its timely impact on infection prevention protocols. Notably, Sobel reported on the successful performance of robot-assisted radical prostatectomy six months after rectal spacer hydrogel injection (SpaceOAR), challenging manufacturer timelines and expanding surgical options for patients who have undergone radiation-sparing procedures. His work bridges clinical innovation with real-world applicability, providing evidence that directly informs surgical decision-making and perioperative care. Sobel’s research is characterized by its practical focus on improving patient outcomes through careful evaluation of new drugs, devices, and safety protocols.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3